Fifteen putative binding sites for 11 different RNA binding proteins were predicted in the region spanning from the −96 position to the starting AUG a region of the p16INK4a 5′UTR where most p16INK4a 5′UTR sequence variants have been reported in melanoma patients [28] (Figure 5A) (see Supplementary Information). The gene discussed is CDKN2A; the disease is melanoma.